Merck & Co Inc [MRK] stock is trading at $93.15, up 0.98%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The MRK shares have gain 2.06% over the last week, with a monthly amount drifted -5.86%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Merck & Co Inc [NYSE: MRK] stock has seen the most recent analyst activity on February 18, 2025, when Deutsche Bank downgraded its rating to a Hold and also revised its price target to $105 from $128. Previously, TD Cowen downgraded its rating to Hold on February 10, 2025, and dropped its price target to $100. On January 08, 2025, downgrade downgraded it’s rating to Hold but maintained its price target of $110 on the stock. BMO Capital Markets downgraded its rating to a Market Perform and decreased its price target to $105 on December 20, 2024. HSBC Securities upgraded its rating to Buy for this stock on December 04, 2024, but kept the price target unchanged to $130. In a note dated November 15, 2024, Wolfe Research initiated an Peer Perform rating.
Merck & Co Inc [MRK] stock has fluctuated between $81.04 and $134.63 over the past year. Currently, Wall Street analysts expect the stock to reach $129.33 within the next 12 months. Merck & Co Inc [NYSE: MRK] shares were valued at $93.15 at the most recent close of the market. An investor can expect a potential return of 38.84% based on the average MRK price forecast.
Analyzing the MRK fundamentals
Merck & Co Inc [NYSE:MRK] reported sales of 63.97B for the trailing twelve months, which represents a growth of 7.60%. Gross Profit Margin for this corporation currently stands at 0.81% with Operating Profit Margin at 0.35%, Pretax Profit Margin comes in at 0.31%, and Net Profit Margin reading is 0.27%. To continue investigating profitability, this company’s Return on Assets is posted at 0.15, Equity is 0.39 and Total Capital is 0.26. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.8.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 92.21 points at the first support level, and at 91.28 for the second support level. However, for the 1st resistance point, the stock is sitting at 93.65, and for the 2nd resistance point, it is at 94.15.
Ratios To Look Out For
For context, Merck & Co Inc’s Current Ratio is 1.36. In addition, the Quick Ratio stands at 1.15 and the Cash Ratio stands at 0.47. Considering the valuation of this stock, the price to sales ratio is 3.68, the price to book ratio is 5.08 and price to earnings (TTM) ratio is 13.83.
Transactions by insiders
Recent insider trading involved Oosthuizen Johannes Jacobus, President, U.S. Market, that happened on Feb 19 ’25 when 8500.0 shares were sold. Officer, JOHANNES JACOBUS OOSTHUIZEN completed a deal on Feb 19 ’25 to buy 8500.0 shares. Meanwhile, Officer DAVID WILLIAMS bought 6000.0 shares on Feb 13 ’25.
